ArticleHaematologica2024

Histamine dihydrochloride and low-dose interleukin-2 has anti-leukemic efficacy in <i>NPM1</i>-mutated and myelomonocytic/monocytic acute myeloid leukemia.

Malin S Nilsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.